Stay updated on Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, reflecting a small maintenance update to the page and no alterations to the study details.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange Detected- Revision updated from v3.6.3 to v3.6.4, indicating a platform/software update to the site. The change does not alter any study data or visible content on the page.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedThe page revision label was updated to v3.6.3, replacing v3.6.2. This indicates a new version of the page's documentation rather than a content change.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, signaling a newer build of the study detail page. This change affects only the page's metadata and does not alter the study content.SummaryDifference0.0%

- Check61 days agoChange DetectedNo longer looking for participants; new sections added for How to Read a Study Record, Common Questions, and How to Join a Study. Intervention/Treatment labeling was updated and the revision note changed to v3.6.0 from v3.5.5.SummaryDifference0.4%

- Check68 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing Revision: v3.5.4, signaling a new version of the page without altering the study content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.